In the multivariate analysis, unfavourable disease-free survival was correlated with preoperational carcinoembryonic antigen levels above 2.12 ng/mL (P = 0.031), confirmed lymphatic metastasis (P < 0.001), and advanced pathological stage (P = 0.012). The gene discussed is CEACAM5; the disease is Lymphatic Metastasis.